These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12805267)

  • 1. The mutant selection window and antimicrobial resistance.
    Drlica K
    J Antimicrob Chemother; 2003 Jul; 52(1):11-7. PubMed ID: 12805267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant selection window hypothesis updated.
    Drlica K; Zhao X
    Clin Infect Dis; 2007 Mar; 44(5):681-8. PubMed ID: 17278059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window.
    Zhao X; Drlica K
    J Infect Dis; 2002 Feb; 185(4):561-5. PubMed ID: 11865411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.
    Blondeau JM
    Vet Dermatol; 2009 Oct; 20(5-6):383-96. PubMed ID: 20178475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related selection of fluoroquinolone-resistant Escherichia coli.
    Olofsson SK; Marcusson LL; Strömbäck A; Hughes D; Cars O
    J Antimicrob Chemother; 2007 Oct; 60(4):795-801. PubMed ID: 17635875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing face of antibiotic prescribing: the mutant selection window.
    Epstein BJ; Gums JG; Drlica K
    Ann Pharmacother; 2004 Oct; 38(10):1675-82. PubMed ID: 15340128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.
    Zhao X; Drlica K
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S147-56. PubMed ID: 11524712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutant selection window in rabbits infected with Staphylococcus aureus.
    Cui J; Liu Y; Wang R; Tong W; Drlica K; Zhao X
    J Infect Dis; 2006 Dec; 194(11):1601-8. PubMed ID: 17083047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.
    Lu T; Zhao X; Li X; Hansen G; Blondeau J; Drlica K
    J Antimicrob Chemother; 2003 Jul; 52(1):61-4. PubMed ID: 12805268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and spread of antibiotic resistance following exposure to antibiotics.
    Cantón R; Morosini MI
    FEMS Microbiol Rev; 2011 Sep; 35(5):977-91. PubMed ID: 21722146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
    Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
    J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
    Allen GP; Hankins CD
    J Antimicrob Chemother; 2009 Aug; 64(2):359-63. PubMed ID: 19460783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.
    Firsov AA; Vostrov SN; Lubenko IY; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2004 May; 23(5):451-6. PubMed ID: 15120722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options in an era of decreasing antimicrobial susceptibility.
    Drlica K; Schmitz FJ
    J Chemother; 2002 Feb; 14 Suppl 2():5-12. PubMed ID: 12003139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
    Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].
    Cui JC; Liu YN; Wang R; Liang BB; Pei F; Zheng ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1863-6. PubMed ID: 15631794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model.
    Allen GP; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2004 Aug; 24(2):150-60. PubMed ID: 15288314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.